Advancing self-management for head and neck cancer-related lymphedema: A promising step forward.

Head and neck cancer (HNC) survivors often experience debilitating lymphedema and fibrosis (LEF). Deng et al conducted a pilot randomized controlled trial (RCT) evaluating a 6-week Lymphedema and Fibrosis Self-Management Program (LEF-SMP), demonstrating high feasibility (93 % adherence) and preliminary efficacy in improving neck mobility, fibrosis symptoms, and quality of life (QoL). While promising, larger, longer-term studies are needed to confirm effectiveness, optimize delivery such as integrating digital health, and ensure accessibility. This study highlights the potential of self-management strategies to empower HNC survivors, complementing traditional therapies and addressing a critical gap in survivorship care. Future research should prioritize diverse populations and cost-effectiveness analyses to enhance clinical implementation.